Increasing the value added and standardizing operations at dispensing pharmacies

「We also established prescription-input centers in Niigata and Gunma prefectures to reduce personnel requirements and enhance pharmacists’ face-to-face services. In addition, some stores are promoting healthcare DX through the installation of dispensing robots and automated reception machines and the introduction of AI medication records, thereby strengthening store functions and improving productivity.」

「In the dispensing pharmacy business, we advanced the reorganization of operating companies, consolidating the 24 dispensing pharmacy operating companies under PharmaCluster Co., Ltd. as of the end of March 2024 into 4 as of 1 April 2026. We also addressed the revision of dispensing fees and established a prescription input center to reduce labor requirements and enhance pharmacists' face-to-face services, centralizing prescription input operations from each store.」

「In the dispensing pharmacy business, we advanced the reorganization of operating companies to implement the transformation of the dispensing pharmacy business, a key measure in the medium-term management plan, consolidating the 24 dispensing pharmacy operating companies under PharmaCluster Co., Ltd. as of the end of March 2024 into 9 as of 1 October this year. We also addressed the revision of dispensing fees, including by obtaining the premium for establishing a system to promote medical DX through increased use of the My Number health insurance card, and worked on home healthcare. In addition, to reduce labor requirements and enhance pharmacists' face-to-face services, we newly established a prescription input center in July this year and began accepting prescription input work from stores.」

「In the dispensing pharmacy business, to implement the transformation of the dispensing pharmacy business, a key measure in the medium-term management plan, we reorganized the 27 dispensing pharmacy operating companies as of the end of March 2024 into 17 as of 1 July this year.」

「In the dispensing pharmacy business, to implement the transformation of the dispensing pharmacy business, a key measure in the medium-term management plan, we reorganized operating companies, opened and closed pharmacies with an emphasis on profitability, and worked to strengthen cooperation with home-care specialty clinics.」

「In the dispensing pharmacy business, we began providing the portal app Kyoso Mirai Pharmacy Kenko Navi, which includes prescription transmission and an electronic medication record, to advance digitalization. In addition, Pharma Mirai is testing a service at its pharmacies using the delivery box Maidoomo Post, developed and operated by Will Port, that allows patients to collect medicines that could not be handed over on the same day at a time convenient for them.」

「In the dispensing pharmacy business, we are promoting new pharmacy openings and closures with an emphasis on profitability. To advance digitalization, we developed the portal app Kyoso Mirai Pharmacy Kenko Navi, which includes prescription transmission and an electronic medication record. We also worked to strengthen cooperation with home-care specialty clinics to advance transformation aimed at contributing to home healthcare. Although the end of transitional measures for the regional support system premium affected technical fees, revenue in the second quarter was ¥46,598 million, up 3.3% year on year, and segment profit (operating profit) was ¥895 million, up 1.9%, due partly to an increase in prescriptions dispensed as patients recovered from refraining from seeking medical care.」

「Although the number of prescriptions dispensed increased as patients recovered from refraining from seeking medical care, revenue was ¥22,827 million, up 2.7% year on year, and segment profit (operating profit) was ¥112 million, down 16.1%, due partly to the end of transitional measures for the regional support system premium, whose eligibility requirements were substantially revised in the April 2022 revision of dispensing fees.」

「In the dispensing pharmacy business, we addressed the revision of medical fees and opened and closed pharmacies with an emphasis on profitability. We also worked to improve patient services through digital tools, including medication guidance using social media, online medication guidance, and promoting use of the prescription transmission app. As a result, revenue was ¥68,843 million, down 0.1% year on year, and segment profit (operating profit) was ¥1,738 million, down 23.8%.」

「In the dispensing pharmacy business, we addressed the revision of medical fees and opened and closed pharmacies based on profitability. We also continued efforts to rationalize and improve the efficiency of operations using the customer support system and to ensure thorough compliance. To improve operational efficiency and patient services through the use of ICT, Kyoso Mirai Akiho Pharmacy in Sakata, Yamagata Prefecture, has participated since October this year in the electronic prescription pilot program and has worked to collect examples of electronic prescription use and identify related issues. In the second quarter, the dispensing pharmacy business was affected by the revisions to drug prices and dispensing fees implemented in April, resulting in revenue of ¥45,089 million, down 0.8% year on year, and segment profit (operating profit) of ¥878 million, down 33.3%.」

「In the dispensing pharmacy business, we worked to enhance patient services by developing regular pharmacists, strengthening online medication guidance, and expanding product sales. We also continued to improve profitability through the rationalization and standardization of operations using the customer support system and a comprehensive review of expenses. However, due to the impact of the revision of dispensing fees implemented in April this year, revenue was ¥22,223 million, down 1.4% year on year, and segment profit (operating profit) was ¥133 million, down 61.9%.」

「In the dispensing pharmacy business, the number of prescriptions dispensed improved as patients became less reluctant to seek medical care. We also actively worked to enhance patient services by strengthening the system for online medication guidance, developing regular pharmacists, and expanding product sales, including OTC medicines, with the aim of providing safe, high-quality medical services. In addition to addressing the revision of dispensing fees, we worked to improve profitability by optimizing inventory and standardizing and streamlining store operations through the customer support system, as well as by comprehensively reviewing expenses. As a result, revenue was ¥91,801 million, up 0.8% year on year, and segment profit (operating profit) was ¥2,963 million, up 10.2%.」

「In the dispensing pharmacy business, we advanced initiatives to improve profitability, including store operations aligned with the direction of dispensing fees, more efficient and standardized operations using the customer support system, and expense reductions and reviews. We also strengthened online medication guidance and promoted medication follow-up using social media, expanded product sales, and began handling antigen test kits in response to requests from the authorities, in addition to working to fulfill our role as patients' regular pharmacy and pharmacist. As a result, revenue was ¥45,450 million, up 0.8% year on year, and segment profit (operating profit) was ¥1,317 million, up 72.6%.」

「In the dispensing pharmacy business, we addressed the revision of dispensing fees and worked to improve profitability through the rationalization and standardization of operations using the customer support system and inventory optimization using the pharmacy headquarters system Mizar. We also enhanced patient services by strengthening the system for online medication guidance, promoting medication follow-up using social media, and expanding product sales. As a result, revenue was ¥22,529 million, up 0.1% year on year, and segment profit (operating profit) was ¥350 million, up 196.0%.」

「In the dispensing pharmacy business, we worked to address the revision of dispensing fees and promote more efficient management by centralizing operations at headquarters. We also worked to improve profitability, including by optimizing inventory through the use of the automatic ordering function based on demand forecasts in the pharmacy headquarters system Mizar. However, partly due to a decrease in prescriptions dispensed as patients refrained from seeking medical care, revenue was ¥68,387 million, down 5.3% year on year, and segment profit (operating profit) was ¥1,742 million, down 2.2%.」

「In the dispensing pharmacy business, we worked to address the revision of dispensing fees and improve profitability by making store operations more efficient and standardized using the customer support system. However, due to a decrease in prescriptions dispensed as patients refrained from seeking medical care, revenue was ¥45,077 million, down 5.5% year on year, and segment profit (operating profit) was ¥763 million, down 43.8%.」

「In the dispensing pharmacy business, we worked to address the revision of dispensing fees and improve profitability by making store operations more efficient and standardized using the customer support system. However, due to a decrease in prescriptions dispensed as patients refrained from seeking medical care, revenue was ¥22,512 million, down 5.1% year on year, and segment profit (operating profit) was ¥118 million, down 82.2%.」

「As a result, revenue for the consolidated fiscal year was ¥96,124 million, up 3.1% from the previous fiscal year, and segment profit (operating profit) was ¥2,700 million, up 89.5%.」

「In the dispensing pharmacy business, we continued to respond to revisions to pharmacy reimbursement and worked to improve profitability through the efficiency and standardization of store operations using customer support systems such as ENIFvoice SP＋A, ENIFvoice Core and the pharmacy headquarters system Mizaru. We also further enhanced training programs, including hospital-based training, as a measure to support changes in pharmacy functions. As a result, revenue was ¥72,216 million, up 3.6% year on year, and segment profit (operating profit) was ¥1,782 million, up 128.1% year on year.」

「In the dispensing pharmacy business, we continued to respond to revisions to pharmacy reimbursement and worked to improve profitability through the efficiency and standardization of store operations using customer support systems such as ENIFvoice SP＋A, ENIFvoice Core and ENIF headquarters. We also further enhanced training programs as a measure to support changes in pharmacy functions. As a result, revenue was ¥47,714 million, up 5.0% year on year, and segment profit (operating profit) was ¥1,358 million, up 573.5% year on year.」

「We worked to improve profitability through the efficiency and standardization of store operations, including reducing overtime hours by using our customer support systems, such as ENIFvoice SP＋A and ENIFvoice Core, while responding to revisions to pharmacy reimbursement. As a result, revenue was ¥23,711 million, up 3.5% year on year, and segment profit (operating profit) was ¥663 million, compared with an operating loss of ¥53 million in the same period of the previous year.」

「In the dispensing pharmacy business, we continued to respond to revisions to pharmacy reimbursement and pursue the standardization and efficiency of store operations through the use of our customer support system, thereby working to improve profitability. Revenue for the consolidated fiscal year was ¥93,222 million, down 4.9% from the previous fiscal year, and segment profit (operating profit) was ¥1,425 million, down 60.0%.」

「In the dispensing pharmacy business, we continued to pursue the efficiency and standardization of store operations through the use of our customer support system, thereby working to improve profitability. However, the business was significantly affected by revisions to pharmacy reimbursement, resulting in revenue of ¥69,674 million, down 4.9% year on year, and segment profit (operating profit) of ¥781 million, down 68.4% year on year.」

「In the dispensing pharmacy business, we continued to pursue the efficiency and standardization of store operations through the use of our customer support system, thereby working to improve profitability. However, the business was significantly affected by revisions to pharmacy reimbursement, resulting in revenue of ¥45,427 million, down 5.8% year on year, and segment profit (operating profit) of ¥201 million, down 84.5% year on year.」

「In the dispensing pharmacy business, we continued to pursue the efficiency and standardization of store operations through the use of our customer support system, thereby working to improve profitability. However, the business was significantly affected by revisions to pharmacy reimbursement, resulting in revenue of ¥22,899 million, down 5.2% year on year, and a segment loss (operating loss) of ¥53 million, compared with segment profit of ¥662 million in the same period of the previous year.」

「In the dispensing pharmacy business, we continued to respond to revisions to pharmacy reimbursement and pursue the standardization and efficiency of store operations through the use of our customer support system, thereby working to improve profitability. As a result, revenue for the consolidated fiscal year was ¥98,019 million, up 2.3% from the previous fiscal year, and segment profit (operating profit) was ¥3,564 million, up 186.5%.」

「In the dispensing pharmacy business, we continued to respond to revisions to pharmacy reimbursement and pursue the standardization and efficiency of store operations through staffing optimization and the use of our customer support system, thereby working to improve profitability. As a result, revenue was ¥73,271 million, up 2.1% year on year, and segment profit (operating profit) was ¥2,472 million, up 208.1% year on year.」

「In the dispensing pharmacy business, we responded to revisions to pharmacy reimbursement and pursued the standardization and efficiency of store operations through staffing optimization and the use of our customer support system, thereby working to improve profitability. As a result, revenue was ¥48,204 million, up 2.2% year on year, and segment profit (operating profit) was ¥1,305 million, up 590.1% year on year.」

「We worked to improve profitability by responding to revisions to pharmacy reimbursement and improving efficiency through standardizing store operations and consolidating operations at headquarters. As a result, revenue was ¥24,147 million, up 2.8% year on year, and segment profit (operating profit) was ¥662 million, compared with an operating loss of ¥118 million in the same period of the previous year.」

「In the dispensing pharmacy business, we pursued measures to establish functions at each pharmacy in response to revisions to pharmacy reimbursement and sought to add value by providing services that meet customer needs through store operations closely connected to community healthcare. We also worked to improve profitability by promoting management efficiency through standardizing store operations and consolidating operations at headquarters. However, the business was significantly affected by revisions to pharmacy reimbursement and drug prices, resulting in revenue of ¥95,807 million, down 4.2% year on year, and segment profit (operating profit) of ¥1,244 million, down 57.4% year on year, for the consolidated fiscal year.」

「In the dispensing pharmacy business, the company was affected by the drug price and pharmacy reimbursement revisions implemented in April 2016. Although cost-reduction measures, including standardizing store operations and consolidating operations at headquarters, were implemented, selling, general and administrative expenses increased because of delays in improving productivity.」

「In the dispensing pharmacy business, there was a delay in adapting to the drug price and pharmacy reimbursement revisions implemented in April this year. Although cost-reduction measures, including standardizing store operations and consolidating operations at headquarters, were implemented, productivity improvements did not progress, resulting in an increase in expenses exceeding the previous year's level.」

「At each store, we worked to strengthen functions in response to revisions to pharmacy reimbursement and to improve value by operating stores as “health-support pharmacies” closely connected to community healthcare and providing services that meet customer needs. We also pursued profitability improvements through cost-reduction measures, including standardizing store operations and consolidating operations at headquarters.」

「We worked to improve profitability by adding value in response to revisions to pharmacy reimbursement, while also pursuing cost-reduction measures through standardizing store operations and consolidating operations at headquarters」